Mail

UK markets closed

FTSE 100
8,237.72
-34.74(-0.42%)
FTSE 250
20,442.35
-56.37(-0.27%)
AIM
772.57
+0.19(+0.02%)
GBP/EUR
1.1822
+0.0000(+0.00%)
GBP/USD
1.2650
-0.0010(-0.08%)
Bitcoin GBP
50,864.21
+112.31(+0.22%)

Homes with impressive sports facilities

Properties with tennis and basketball courts to pools and even a football pitch at the doorstep

Guangdong Taiantang Pharmaceutical Co., Ltd. (002433.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY

Add to watchlist

0.2300

-0.0100

(-4.17%)

At close: 03:04PM CST

Currency in CNY

Valuation measures⁴

Market cap (intra-day)	176.36M
Enterprise value	1.33B
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.52
Price/book (mrq)	0.46
Enterprise value/revenue	3.92
Enterprise value/EBITDA	-2.44

Trading information

Stock price history

Beta (5Y monthly)	0.01
52-week change ³	-87.89%
S&P500 52-week change ³	26.24%
52-week high ³	3.3500
52-week low ³	0.1900
50-day moving average ³	0.5122
200-day moving average ³	1.9611

Share statistics

Avg vol (3-month) ³	8.27M
Avg vol (10-day) ³	35.95M
Shares outstanding ⁵	766.77M
Implied shares outstanding ⁶	809.37M
Float ⁸	618.95M
% held by insiders ¹	24.89%
% held by institutions ¹	0.00%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	0.30
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	17 Jul 2020
Last split factor ²	20:10
Last split date ³	22 Apr 2014

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	0.00%
Operating margin (ttm)	-38.60%

Management effectiveness

Return on assets (ttm)	-21.05%
Return on equity (ttm)	-114.26%

Income statement

Revenue (ttm)	339.65M
Revenue per share (ttm)	0.44
Quarterly revenue growth (yoy)	-50.80%
Gross profit (ttm)	N/A
EBITDA	-1.54B
Net income avi to common (ttm)	-2.2B
Diluted EPS (ttm)	-2.8700
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	93.59M
Total cash per share (mrq)	0.12
Total debt (mrq)	855.13M
Total debt/equity (mrq)	251.12%
Current ratio (mrq)	0.49
Book value per share (mrq)	0.50

Cash flow statement

Operating cash flow (ttm)	-11.46M
Levered free cash flow (ttm)	1.96B